Synlab launches Frankfurt IPO after strong 2020

By Aidan Gregory
07 Apr 2021

Synlab, the German laboratory diagnostic services company, has announced its intention to float on the Frankfurt Stock Exchange.

In a statement, Synlab said it would sell €400m of new shares, to fund deleveraging. The company’s owner Cinven, as well as Nordic life sciences investment company Novo Holdings and Ontario Teachers’ Pension Plan Board, the Canadian pension fund are also expected to sell down some of their ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial